Nov 27, 2025 New Product Announcement of the Launch of Ionomycin, an Oocyte Activation Reagent We are pleased to announce the launch of Ionomycin, an oocyte activation reagent developed for use in assisted reproductive technology. This reagent supplies the energy required for oocyte fertilization and is indicated for patients with fertilization disorders as well as for those exhibiting age-related declines in oocyte activity. By improving fertilization rates, it contributes to enhanced pregnancy outcomes. We will continue to promote the development of products that contribute to the advancement of reproductive medicine. Back to News List
